Author/Authors :
Al-Taweel, Areej Mohamed Department of Pharmacognosy - College of Pharmacy - King Saud University - Riyadh - Kingdom of Saudi Arabia , Fawzy, Ghada Ahmed Department of Pharmacognosy - College of Pharmacy - King Saud University - Riyadh - Kingdom of Saudi Arabia - Department of Pharmacognosy - Faculty of Pharmacy - Cairo University - Cairo 11562, Egypt , Perveen, Shagufta Department of Pharmacognosy - College of Pharmacy - King Saud University - Riyadh - Kingdom of Saudi Arabia
Abstract :
Five flavonoid glycosides were isolated from the n-butanol soluble fraction of the ethanolic extract of Rapistrum rugosum and their structures were assigned from 1H- and 13C-NMR spectra (DEPT) with 2D NMR as quercetin-3-O-α-L-rhamnopyranoside (1), quercetin-3-O- β-D-xyloside (2), quercetin, 3-O-α-L-arabinopyranoside,7-O-α-L-rhamnopyranoside (3), kaempferol 3-O-α-L-arabinopyranoside, 7-O-α-L- rhamnopyranoside (4) and rutin (5). The SRB cytotoxic assay was used to investigate the antitumor activities of n-butanol extract, compound 3 and its hexaacetate 3a, for the first time. Compounds 3 and 3a showed cytotoxic activity against the human cancer cell line, namely, HepG2 (hepatocellular carcinoma cell line) with IC50 (concentration of compound required to reduce cell survival by 50%) 0.86 μg/mL
and 3.50 μg/mL, respectively. These results proved that compound 3, the major flavonoid of the n-butanol soluble fraction, has significant cytotoxic activity compared with the standard antitumor drug doxorubicin (0.60 μg/mL).
Keywords :
SRB cytotoxic assay , Rapistrum rugosum , Flavonoid glycosides , n-butanol